BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35933270)

  • 21. Nodal Yield <15 Is Associated With Reduced Survival in Esophagectomy and Is a Quality Metric.
    Bolger JC; Castro PP; Marwah A; Tavakoli I; Espin-Garcia O; Darling GE; Yeung JC
    Ann Thorac Surg; 2023 Jul; 116(1):130-136. PubMed ID: 36918078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy.
    Samson P; Puri V; Broderick S; Patterson GA; Meyers B; Crabtree T
    Ann Thorac Surg; 2017 Feb; 103(2):406-415. PubMed ID: 28024648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical transhiatal esophagectomy with two-field lymphadenectomy and endodissection for distal esophageal adenocarcinoma.
    Bumm R; Feussner H; Bartels H; Stein H; Dittler HJ; Höfler H; Siewert JR
    World J Surg; 1997 Oct; 21(8):822-31. PubMed ID: 9327673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved Tissue Processing in Esophageal Adenocarcinoma After Ivor Lewis Esophagectomy Allows Histological Analysis of All Surgically Removed Lymph Nodes with Significant Effects on Nodal UICC Stages.
    Quaas A; Schloesser H; Fuchs H; Zander T; Arolt C; Scheel AH; Rueschoff J; Bruns C; Buettner R; Schroeder W
    Ann Surg Oncol; 2021 Jul; 28(7):3975-3982. PubMed ID: 33305335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation.
    Ho HJ; Chen HS; Hung WH; Hsu PK; Wu SC; Chen HC; Wang BY
    Ann Surg Oncol; 2018 Dec; 25(13):3820-3832. PubMed ID: 30284131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival risk prediction model for patients with pT
    Qi Z; Hu Y; Qiu R; Li J; Li Y; He M; Wang Y
    J Cardiothorac Surg; 2021 May; 16(1):121. PubMed ID: 33933129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implications of lymphadenectomy in esophageal cancer after neo-adjuvant therapy: a single center experience.
    Torgersen Z; Sundaram A; Hoshino M; Willer B; Fang X; Tashi T; Lee T; Mittal SK
    J Gastrointest Surg; 2011 Oct; 15(10):1769-76. PubMed ID: 21809165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of Lymph Node Yield on Overall Survival in Esophageal Cancer Patients: A Systematic Review and Meta-analysis.
    Visser E; Markar SR; Ruurda JP; Hanna GB; van Hillegersberg R
    Ann Surg; 2019 Feb; 269(2):261-268. PubMed ID: 29794846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resection of the irradiated esophagus: the impact of lymph node yield on survival.
    Esposito VR; Yerokun BA; Mulvihill MS; Cox ML; Andrew BY; Yang CJ; Choi AY; Moore C; D'Amico TA; Tong BC; Hartwig MG
    Dis Esophagus; 2020 Oct; 33(10):. PubMed ID: 32115648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphadenectomy and Survival After Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma: Is More Better?
    de Geus SWL; Hirji S; Hachey KJ; Sachs TE; Suzuki K; Ng SC; Swanson S; Litle VR; D'Amico T; Tseng JF
    J Gastrointest Surg; 2020 Nov; 24(11):2447-2455. PubMed ID: 32875442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.
    Rice TW; Ishwaran H; Hofstetter WL; Schipper PH; Kesler KA; Law S; Lerut EM; Denlinger CE; Salo JA; Scott WJ; Watson TJ; Allen MS; Chen LQ; Rusch VW; Cerfolio RJ; Luketich JD; Duranceau A; Darling GE; Pera M; Apperson-Hansen C; Blackstone EH
    Ann Surg; 2017 Jan; 265(1):122-129. PubMed ID: 28009736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction.
    Anderegg MC; Lagarde SM; Jagadesham VP; Gisbertz SS; Immanuel A; Meijer SL; Hulshof MC; Bergman JJ; van Laarhoven HW; Griffin SM; van Berge Henegouwen MI
    Ann Surg; 2016 Nov; 264(5):847-853. PubMed ID: 27429034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma.
    Swanson SJ; Batirel HF; Bueno R; Jaklitsch MT; Lukanich JM; Allred E; Mentzer SJ; Sugarbaker DJ
    Ann Thorac Surg; 2001 Dec; 72(6):1918-24; discussion 1924-5. PubMed ID: 11789772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients.
    Wang Y; Zhang X; Zhang X; Liu-Helmersson J; Zhang L; Xiao W; Jiang Y; Liu K; Sang S
    BMC Cancer; 2021 Apr; 21(1):403. PubMed ID: 33853577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.
    Li B; Hu H; Zhang Y; Zhang J; Miao L; Ma L; Luo X; Zhang Y; Ye T; Li H; Zhou J; Li Y; Shen L; Zhao K; Fan M; Zhu Z; Wang J; Xu J; Deng Y; Lu Q; Jia H; Cheng X; Li H; Zhang Y; Li C; Pan Y; Liu S; Hu H; Shao L; Sun Y; Xiang J; Chen H
    Ann Surg; 2018 May; 267(5):826-832. PubMed ID: 28448385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Significance of Sentinel Node Positivity in Patients with Superficial Esophageal Cancer.
    Takeuchi H; Kawakubo H; Nakamura R; Fukuda K; Takahashi T; Wada N; Kitagawa Y
    World J Surg; 2015 Dec; 39(12):2941-7. PubMed ID: 26296842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus.
    Altorki N; Kent M; Ferrara C; Port J
    Ann Surg; 2002 Aug; 236(2):177-83. PubMed ID: 12170022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.
    Jang HJ; Lee HS; Kim MS; Lee JM; Zo JI
    Ann Thorac Surg; 2011 Sep; 92(3):1091-7. PubMed ID: 21704967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
    Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
    World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended Lymphadenectomy Improves Survival After Induction Chemoradiation for Esophageal Cancer: A Propensity-Matched Analysis of the National Cancer Database.
    Kamel MK; Harrison S; Lee B; Port JL; Stiles BM; Altorki NK
    Ann Surg; 2023 Apr; 277(4):e772-e776. PubMed ID: 34475320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.